Table 1 Clinical characteristics of patients in Group A and Group B
Characteristics | Group A (n = 66) | Group B (n = 32) | p value | ||
|---|---|---|---|---|---|
n | % | n | % | ||
Gender | 0.147 | ||||
Male | 52 | 78.8 | 29 | 90.6 | |
Female | 14 | 21.2 | 3 | 9.4 | |
Age (year) | 0.433 | ||||
Median | 61 | 56 | |||
Range | 40-80 | 40-78 | |||
ECOG PS | 0.351 | ||||
0 | 22 | 33.3 | 10 | 31.3 | |
1 | 44 | 66.7 | 21 | 65.6 | |
2 | 0 | 0 | 1 | 3.1 | |
Hepatitis | 0.484 | ||||
HBV | 47 | 71.2 | 24 | 75.0 | |
HCV | 6 | 9.1 | 2 | 6.3 | |
Others | 13 | 19.7 | 6 | 18.9 | |
Liver cirrhosis | 0.279 | ||||
No | 14 | 21.2 | 10 | 31.2 | |
Yes | 52 | 78.8 | 22 | 68.8 | |
PVTT | 0.677 | ||||
No | 28 | 42.4 | 15 | 46.9 | |
Yes | 38 | 57.6 | 17 | 53.1 | |
AFP (IU/mL) | 0.190 | ||||
<400 | 45 | 68.2 | 18 | 56.3 | |
≥400 | 21 | 31.8 | 14 | 43.7 | |
Child-Pugh class | 0.059 | ||||
A | 49 | 74.2 | 29 | 90.6 | |
B | 17 | 25.8 | 3 | 9.4 | |
AJCC stage | 0.741 | ||||
II | 12 | 18.2 | 4 | 12.5 | |
III | 47 | 71.2 | 25 | 78.1 | |
IV | 7 | 10.6 | 3 | 9.4 | |
Previous treatment | 0.964 | ||||
No | 7 | 10.6 | 3 | 9.4 | |
Yes | 59 | 89.4 | 29 | 90.6 | |
TACE | 58 | 87.9 | 28 | 87.5 | |
RFA | 7 | 10.6 | 2 | 6.3 | |
PEI | 7 | 10.6 | 3 | 9.4 | |
Surgery | 9 | 13.6 | 7 | 21.9 | |
Treatment after RT | 0.180 | ||||
No | 31 | 47.0 | 10 | 31.3 | |
Yes | 35 | 53.0 | 22 | 68.8 | |
TACE | 35 | 53.0 | 22 | 68.8 | |
RFA | 2 | 3.0 | 0 | 0 | |
PEI | 2 | 3.0 | 1 | 3.1 | |
Systemic CTx | 3 | 4.5 | 3 | 9.4 | |